Menu
Search
|

Menu

Close
X

OraSure Technologies Inc OSUR.OQ (NASDAQ Stock Exchange Global Select Market)

16.91 USD
-- (--)
As of Jul 19
chart
Previous Close 16.91
Open --
Volume --
3m Avg Volume 179,927
Today’s High --
Today’s Low --
52 Week High 23.00
52 Week Low 12.86
Shares Outstanding (mil) 59.46
Market Capitalization (mil) 1,322.97
Forward P/E 41.42
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.20 Mean rating from 5 analysts

KEY STATS

Revenue (mm, USD)
FY18
42
FY17
167
FY16
128
FY15
120
EPS (USD)
FY18
-0.035
FY17
0.636
FY16
0.348
FY15
0.144
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
41.42
32.76
Price to Sales (TTM)
vs sector
9.42
5.73
Price to Book (MRQ)
vs sector
5.75
5.47
Price to Cash Flow (TTM)
vs sector
35.65
23.29
Total Debt to Equity (MRQ)
vs sector
0.00
16.84
LT Debt to Equity (MRQ)
vs sector
0.00
12.51
Return on Investment (TTM)
vs sector
15.31
14.61
Return on Equity (TTM)
vs sector
15.72
16.34

EXECUTIVE LEADERSHIP

Stephen Tang
Chairman of the Board, President, Chief Executive Officer, Since 2018
Salary: --
Bonus: --
Roberto Cuca
Chief Financial Officer, Since 2018
Salary: --
Bonus: --
Anthony Zezzo
Executive Vice President - Marketing and Sales, Since 2011
Salary: $391,572.00
Bonus: $188,998.00
Mark Kuna
Senior Vice President - Finance, Controller, Assistant Secretary, Since 2006
Salary: $261,783.00
Bonus: $127,060.00
Michael Reed
Senior Vice President - Research and Development, Chief Scientific Officer, Since 2016
Salary: $211,154.00
Bonus: $128,773.00

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

150 WEBSTER ST
BETHLEHEM   PA   18015

Phone: +1503.6416115

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. It sells over-the-counter (OTC) cryosurgical products to consumers in North America, Europe, Central and South America, and Australia.

SPONSORED STORIES